Kenvue Inc. (NYSE:KVUE) has been given a consensus recommendation of "Hold" by multiple brokerages. Ahead of its Q1 results, Kenvue is anticipated to surpass earning estimates. Despite a
class action lawsuit filed against Kenvue, it appears that their stock continues to appeal to many
investors who see it as a potential solution for investment headaches.
Susquehanna Fundamental Investments LLC made a new $5.12 million investment in Kenvue and other notable investments have been made by the Manufacturers Life Insurance Company and Northern Trust Corp. Kenvue's quarter results will be announced on May 8, 2025. Its new
52-week high has several contemplating if it's still a good buy. The company announced a new
$0.205 dividend, demonstrating solid financial strength. Though Kenvue faces struggles with growth, it is considered a good buy among defensive dividend stocks. Kenvue recently revealed a collaboration with Microsoft, which is expected to revolutionize consumer health. It's also been reported that Third Point has increased its stake in the company. They will be declaring a cash dividend soon.
Starboard Value has agreed to new Board directors as Kenvue continues to revamp digital operations.
Kenvue KVUE News Analytics from Thu, 16 Jan 2025 08:00:00 GMT to Sat, 03 May 2025 19:04:46 GMT -
Rating 7
- Innovation 6
- Information 6
- Rumor 4
